In the midst of an ongoing nationwide opioid crisis, the global COVID-19 pandemic has significantly impacted people with substance use disorders – and particularly opioid use disorders. Social distancing requirements, shelter-in-place orders and the many unknowns about this coronavirus have created challenges for ensuring access to prevention and treatment services. “The COVID-19 pandemic created additional challenges for people with substance use disorders and those at risk of developing problems, but treatment providers, policymakers and researchers have been working to find new ways for people to get the help they need during this time,” said Hillary Samples, a faculty member of the Center for Health Services Research at the Rutgers Institute for Health, Health Care Policy and Aging Research and an assistant professor at the Rutgers School of Public Health. To read the full story.
Recent Posts
- A $750 million effort to revolutionize cancer care in N.J. opens next month.
- New study raises alarm over Alzheimer’s blood tests.
- Elevated Serum cAMP Findings May Allow Asthma Diagnosis by Blood Test.
- Tariffs could have deep impacts on costs for prescription drugs: What to know.
- New NJACTS Publication
Categories
- Community (2,215)
- Covid (985)
- CTO Events (6)
- News (2,826)
- Pilots (21)